IPN.PA
Price:
$160.4
Market Cap:
$13.26B
Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide. Its oncology products include Somatuline for the treatment of neuroendocrine tumors and acromegaly; Cabometyx, a tyrosine kinase inhibitor to treat second line pancreatic and extra-pancreatic neuroendocrine tumors; Onivyde, an irinotecan liposome injection for the treatment of pancreatic cancer; Decapeptyl for the treatment of advanced metastatic prostate cancer; Tazverik, a chemotherapy-free EZH2a inhibitor that is in phase III clinical trial for the treatment of second line follicular lymphoma; Tovorafenib that is in phase III clinical trial to ...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2005-12-07
Stock Exchange
PAR
Ticker
IPN.PA
Dividends are a key part of long-term returns for investors, and Ipsen S.A. (IPN.PA) has a track record worth reviewing. Looking at dividend history for IPN.PA gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2026-06-03
Dividend Yield
1.00%
Annual Dividend
$1.60
P/E Ratio
16.01
Payout Ratio
0.26
Dividend per Share
$1.60
EPS
10.02
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2026-06-03 | $1.6 | $1.6 | 2026-06-05 | |
| 2025-06-04 | $1.4 | $1.4 | 2025-06-06 | |
| 2024-05-30 | $1.2 | $1.2 | 2024-06-03 | 2024-05-31 |
| 2023-06-02 | $1.2 | $1.2 | 2023-06-06 | |
| 2022-05-31 | $1.2 | $1.2 | 2022-06-02 | |
| 2021-05-31 | $1 | $1 | 2021-06-02 | |
| 2020-06-03 | $1 | $1 | 2020-06-05 | 2020-02-13 |
| 2019-05-31 | $1 | $1 | 2019-06-04 | 2019-02-14 |
| 2018-06-04 | $1 | $1 | 2018-06-06 | 2017-12-06 |
| 2017-06-09 | $0.85 | $0.85 | 2017-06-13 | 2017-02-23 |
| 2016-06-02 | $0.85 | $0.85 | 2016-06-06 | 2016-03-01 |
The table below shows Ipsen S.A. (IPN.PA) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Ipsen S.A. (IPN.PA) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|---|
| Eurofins Scientific SE (ERF.PA) | 0.01% |
| bioMérieux S.A. (BIM.PA) | 0.01% |
| Boiron S.A. (BOI.PA) | 0.05% |
| Vetoquinol S.A. (VETO.PA) | 0.01% |
| Virbac S.A. (VIRP.PA) | 0.00% |
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Ipsen S.A. (IPN.PA) without the pain and hassle of copy pasting data.
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is IPN.PA’s dividend yield?
What is the difference between regular and special dividends?
Has IPN.PA increased its dividends over time?
Why might dividend history data be delayed?
How often does IPN.PA pay dividends?
What factors impact IPN.PA's dividend payments?
Can dividends change over time?
What is IPN.PA’s next dividend date?